IFNA1 and autoimmune disease: Many studies have reported that suppression of MHC-I and IFN signaling downregulates inflammation in numerous diseases (e.g., infectious disease, cancer, autoimmune disease) (29–34), highlighting the potential to treat asthma exacerbation by targeting these pathways.